Company: LENZ
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001815776-25-000019
Chunk: 156

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 11
Chunk 156
---
Item 11. Executive Compensation 

To achieve our goals, we have designed, and intend to modify as necessary, our compensation and benefits program to attract, retain, incentivize and reward deeply talented and qualified executives who share our philosophy and desire to work towards achieving these goals.

We believe our compensation program should promote the success of the company and align executive incentives with the long-term interests of our stockholders. As our needs evolve, we intend to continue to evaluate our philosophy and compensation programs as circumstances require.

This section provides an overview of our and LENZ OpCo's executive compensation programs, including a narrative description of the material factors necessary to understand the information disclosed in the summary compensation table below. Unless otherwise indicated, as used in this section, “LENZ,” the “Company,” “we,” “us” and “our” refer to LENZ OpCo prior to the closing of the Merger and the Company after the closing of the Merger. Upon the closing of the Merger, the executive officers of LENZ OpCo became executive officers of the Company.

Our named executive officers for the year ended December 31, 2024 were:

•Evert Schimmelpennink, Chief Executive Officer, President, and Secretary since the closing of the Merger

•Kimberlee C. Drapkin, former interim President and Chief Executive Officer 

•Marc Odrich, Chief Medical Officer

•Daniel Chevallard, Chief Financial Officer

Summary Compensation Table for the Fiscal Year Ended December 31, 2024

The following table shows the compensation earned by our named executive officers for the fiscal years ended December 31, 2024 and 2023.

137

Table of Contents

Name and principal positionYearSalary ($)Bonus ($)(1)Non-equity incentive plan compensation ($)(2)Option awards ($)(3)All other compensation ($)Total ($)Evert SchimmelpenninkPresident and Chief Executive Officer2024607,125 (4)— 450,450 5,912,135 13,800 (5)6,983,510 2023537,438 (6)335,898 — 1,630,871 13,200 (5)2,517,407 Kimberlee C. Drapkin(7)Former Interim President and Chief Executive Officer, and Director2024163,541 (8)200,000 (9)— 333,804 (10)400,000 (9